Suchergebnisse - "Xia, Zhongjun"

PubPharm (76)

31

Comparison of chemotherapy with or without asparaginase for extranodal nasal NK/T-cell lymphoma in children and adolescents

enthalten in: Pediatric blood & cancer | 2021

von Zhen, Z. | Huang, H. | Lin, T. | +9

32

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China

enthalten in: International journal of hematology | 2021

von Du, J. | Fang, B. | Li, J. | +16

33

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China

enthalten in: International journal of hematology | 2021

von Du, J. | Fang, B. | Li, J. | +16

34

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China

enthalten in: International journal of hematology | 2021

von Du, J. | Fang, B. | Li, J. | +16

35

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China

enthalten in: International journal of hematology | 2021

von Du, J. | Fang, B. | Li, J. | +16

36

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/ T‐ cell lymphoma : A multicenter study

enthalten in: American Journal of Hematology | 2021

von Zhang, Y. | Ma, S. | Cai, J. | +17

37

Comparison of chemotherapy with or without asparaginase for extranodal nasal NK/T‐cell lymphoma in children and adolescents

enthalten in: Pediatric Blood & Cancer | 2021

von Zhen, Z. | Huang, H. | Lin, T. | +9

38

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial : a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

39

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

40

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17